Patient selection for lung volume reduction surgery

Area of Science:

• Pulmonary Medicine
• Thoracic Surgery
• Health Economics

Background:

• Symptomatic emphysema significantly impacts patient quality of life.
• Lung Volume Reduction Surgery (LVRS) is a potential treatment for severe emphysema.
• Objective data on LVRS outcomes and cost-effectiveness are crucial for clinical decision-making.

Purpose of the Study:

• To evaluate the outcomes and cost-effectiveness of LVRS in patients with symptomatic emphysema.
• To present a validated algorithm for selecting optimal candidates for LVRS.
• To analyze the costs and benefits of LVRS using data from the National Emphysema Treatment Trial (NETT).

Main Methods:

• Review of controlled studies on LVRS outcomes.
• Development and validation of a patient selection algorithm.
• Analysis of cost data collected simultaneously with clinical outcomes in the NETT.

Main Results:

• LVRS is a valid surgical option for a carefully selected group of patients with symptomatic emphysema.
• A validated algorithm now exists for identifying optimal candidates for LVRS.
• NETT data provide a unique perspective on the costs and benefits of LVRS in advanced emphysema.

Conclusions:

• LVRS is a beneficial intervention for a specific subset of patients with emphysema.
• The validated selection algorithm enhances the precision of patient candidacy for LVRS.
• Ongoing data collection is essential to fully understand the long-term advantages of LVRS for Chronic Obstructive Pulmonary Disease (COPD).